The impact of vitamin D on the innate immune response to uropathogenic Escherichia coli during pregnancy

Clinical Microbiology and Infection

Volumn 21, Issue 5, 2015, Pages 482.e1-482.e7

  Ramos, N L ^a   Sekikubo, M ^a,b   Kironde, F ^b   Mirembe, F ^b   Saaf M ^a,c   Brauner, A ^a  

^a KAROLINSKA UNIVERSITY HOSPITAL   (Sweden)

^b MAKERERE UNIVERSITY   (Uganda)

^c KAROLINSKA INSTITUTE   (Sweden)

Author keywords

25 hydroxyvitamin D; Escherichia coli; Interleukin 8; LL 37; Pregnancy; Urinary tract infection

Indexed keywords

25 HYDROXYVITAMIN D; BETA DEFENSIN 2; CALCITRIOL; CATHELICIDIN ANTIMICROBIAL PEPTIDE LL 37; CD14 ANTIGEN; INTERLEUKIN 8; VITAMIN D; BIOLOGICAL MARKER; IMMUNOLOGIC FACTOR;

ADULT; ARTICLE; BACTERIAL GROWTH; BLADDER EPITHELIUM; BLOOD LEVEL; CHEMOLUMINESCENCE; CLINICAL ARTICLE; CONTROLLED STUDY; DELIVERY; ENZYME LINKED IMMUNOSORBENT ASSAY; FEMALE; FIRST TRIMESTER PREGNANCY; GROWTH INHIBITION; HUMAN; HUMAN CELL; IMMUNOMODULATION; IN VITRO STUDY; INNATE IMMUNITY; MATERNAL AGE; MULTIGRAVIDA; NONHUMAN; PREGNANCY; PRIMIGRAVIDA; PRIORITY JOURNAL; SUN EXPOSURE; THIRD TRIMESTER PREGNANCY; UGANDAN; UROPATHOGENIC ESCHERICHIA COLI; ADOLESCENT; BLOOD; DRUG EFFECTS; ESCHERICHIA COLI INFECTION; IMMUNOLOGY; LUMINESCENCE; METABOLISM; PREGNANCY COMPLICATION; UGANDA; URINARY TRACT INFECTION; YOUNG ADULT;

ESCHERICHIA COLI;

ADOLESCENT; ADULT; BIOMARKERS; ENZYME-LINKED IMMUNOSORBENT ASSAY; ESCHERICHIA COLI INFECTIONS; FEMALE; HUMANS; IMMUNITY, INNATE; IMMUNOLOGIC FACTORS; LUMINESCENT MEASUREMENTS; PREGNANCY; PREGNANCY COMPLICATIONS, INFECTIOUS; UGANDA; URINARY TRACT INFECTIONS; UROPATHOGENIC ESCHERICHIA COLI; VITAMIN D; YOUNG ADULT;

EID: 84930526201     PISSN: 1198743X     EISSN: 14690691     Source Type: Journal    
DOI: 10.1016/j.cmi.2014.12.010     Document Type: Article

References (32)

1. Foxman B. Epidemiology of urinary tract infections: incidence, morbidity, and economic costs. Am J Med 2002, 113(Suppl.1A):5S-13S.
2. Delzell J.E., Lefevre M.L. Urinary tract infections during pregnancy. Am Fam Physician 2000, 61(3):713-721.
3. Mazor-Dray E., Levy A., Schlaeffer F., Sheiner E. Maternal urinary tract infection: is it independently associated with adverse pregnancy outcome?. JMaternal-Fetal Neonatal Med 2009, 22(2):124-128.
4. Lips P., van Schoor N.M., de Jongh R.T. Diet, sun, and lifestyle as determinants of vitamin D status. Ann N Y Acad Sci 2014, 1317(1):92-98.
5. Holick M.F. Vitamin D status: measurement, interpretation, and clinical application. Ann Epidemiol 2009, 19(2):73-78.
6. Holick M.F. Vitamin D deficiency. NEngl J Med 2007, 357(3):266-281.
7. Sääf M., Fernell E., Kristiansson F. Barnevik Olsson M, Gustafsson SA, Bågenholm G. Severe vitamin D deficiency in pregnant women of Somali origin living in Sweden. Acta Paediatr 2011, 100(4):612-614.
8. Javaid M.K., Crozier S.R., Harvey N.C., Gale C.R., Dennison E.M., Boucher B.J., et al. Maternal vitamin D status during pregnancy and childhood bone mass at age 9 years: a longitudinal study. Lancet 2006, 367(9504):36-43.
9. Hertting O., Holm A., Luthje P., Brauner H., Dyrdak R., Jonasson A.F., et al. Vitamin D induction of the human antimicrobial peptide cathelicidin in the urinary bladder. PloS One 2010, 5(12):e15580.
10. Liu P.T., Stenger S., Tang D.H., Modlin R.L. Cutting edge: vitamin D-mediated human antimicrobial activity against Mycobacterium tuberculosis is dependent on the induction of cathelicidin. JImmunol 2007, 179(4):2060-2063.
11. Wang T.T., Nestel F.P., Bourdeau V., Nagai Y., Wang Q., Liao J., et al. Cutting edge: 1,25-dihydroxyvitamin D3 is a direct inducer of antimicrobial peptide gene expression. JImmunol 2004, 173(5):2909-2912.
12. Chun R.F., Liu P.T., Modlin R.L., Adams J.S., Hewison M. Impact of vitamin D on immune function: lessons learned from genome-wide analysis. Front Physiol 2014, 5:1-15. Article ID: 151.
13. Khoo A.L., Chai L.Y., Koenen H.J., Oosting M., Steinmeyer A., Zuegel U., et al. Vitamin D(3) down-regulates proinflammatory cytokine response to Mycobacterium tuberculosis through pattern recognition receptors while inducing protective cathelicidin production. Cytokine 2011, 55(2):294-300.
14. Fazliana M., Ramos N.L., Luthje P., Sekikubo M., Holm A., Wan Nazaimoon W.M., et al. Labisia pumila var. alata reduces bacterial load by inducing uroepithelial cell apoptosis. JEthnopharmacol 2011, 136(1):111-116.
15. Chromek M., Slamova Z., Bergman P., Kovacs L., Podracka L., Ehren I., et al. The antimicrobial peptide cathelicidin protects the urinary tract against invasive bacterial infection. Nat Med 2006, 12(6):636-641.
16. von Minckwitz G., Grischke E.M., Schwab S., Hettinger S., Loibl S., Aulmann M., et al. Predictive value of serum interleukin-6 and -8 levels in preterm labor or rupture of the membranes. Acta Obstet Gynecol Scand 2000, 79(8):667-672.
17. Bäckhed F., Meijer L., Normark S., Richter-Dahlfors A. TLR4-dependent recognition of lipopolysaccharide by epithelial cells requires sCD14. Cell Microbiol 2002, 4(8):493-501.
18. Webb A.R., Engelsen O. Calculated ultraviolet exposure levels for a healthy vitamin D status. Photochem Photobiol 2006, 82(6):1697-1703.
19. Charatcharoenwitthaya N., Nanthakomon T., Somprasit C., Chanthasenanont A., Chailurkit L.O., Pattaraarchachai J., et al. Maternal vitamin D status, its associated factors and the course of pregnancy in Thai women. Clin Endocrinol 2013, 78(1):126-133.
20. Vandevijvere S., Amsalkhir S., Van Oyen H., Moreno-Reyes R. High prevalence of vitamin D deficiency in pregnant women: a national cross-sectional survey. PloS One 2012, 7(8):e43868.
21. Narchi H., Kochiyil J., Zayed R., Abdulrazzak W., Agarwal M. Maternal vitamin D status throughout and after pregnancy. JObstet Gynaecol 2010, 30(2):137-142.
22. Powe C.E., Evans M.K., Wenger J., Zonderman A.B., Berg A.H., Nalls M., et al. Vitamin D-binding protein and vitamin D status of black Americans and white Americans. NEngl J Med 2013, 369(21):1991-2000.
23. van der Does A.M., Bergman P., Agerberth B., Lindbom L. Induction of the human cathelicidin LL-37 as a novel treatment against bacterial infections. JLeukocyte Biol 2012, 92(4):735-742.
24. Mandic Havelka A., Yektaei-Karin E., Hultenby K., Sorensen O.E., Lundahl J., Berggren V., et al. Maternal plasma level of antimicrobial peptide LL37 is a major determinant factor of neonatal plasma LL37 level. Acta Paediatr 2010, 99(6):836-841.
25. Chen X., Niyonsaba F., Ushio H., Okuda D., Nagaoka I., Ikeda S., et al. Synergistic effect of antibacterial agents human beta-defensins, cathelicidin LL-37 and lysozyme against Staphylococcus aureus and Escherichia coli. JDermatol Sci 2005, 40(2):123-132.
26. Gunville C.F., Mourani P.M., Ginde A.A. The role of vitamin D in prevention and treatment of infection. Inflamm Allergy Drug Targets 2013, 12(4):239-245.
27. Schminkey D.L., Groer M. Imitating a stress response: a new hypothesis about the innate immune system's role in pregnancy. Med Hypotheses 2014, 82(6):721-729.
28. Schilling J.D., Martin S.M., Hunstad D.A., Patel K.P., Mulvey M.A., Justice S.S., et al. CD14- and Toll-like receptor-dependent activation of bladder epithelial cells by lipopolysaccharide and type 1 piliated Escherichia coli. Infect Immun 2003, 71(3):1470-1480.
29. Savvidou M.D., Makgoba M., Castro P.T., Akolekar R., Nicolaides K.H. First-trimester maternal serum vitamin D and mode of delivery. Br J Nutr 2012, 108(11):1972-1975.
30. Holick M.F., Binkley N.C., Bischoff-Ferrari H.A., Gordon C.M., Hanley D.A., Heaney R.P., et al. Evaluation, treatment, and prevention of vitamin D deficiency: an Endocrine Society clinical practice guideline. JClin Endocrinol Metab 2011, 96(7):1911-1930.
31. Thandrayen K., Pettifor J.M. Maternal vitamin D status: implications for the development of infantile nutritional rickets. Rheumatic Dis Clin North Am 2012, 38(1):61-79.
32. Kovacs C.S. Maternal vitamin D deficiency: fetal and neonatal implications. Semin Fetal Neonatal Med 2013, 18:129-135.